Bergmann, University of Southern Denmark, Denmark Updates Copyright 2021 Fontova, Colom, Rigo-Bonnin, van Merendonk, Vidal-Alabr, Montero, Melilli, Meneghini, Manonelles, Cruzado, Torras, Griny, Bestard and Lloberas
Sermorelin was FDA-approved to treat growth hormone deficiency in children when researchers discovered it could stimulate the pituitary gland to pump out more HGH
Nevertheless, the authors advertise CJC-1295's excellent safety profile, which can only be said on an individual basisin most cases, study participants did not complete the long-term trial
The central marker is IGF-1, which reflects growth hormone activity
It should not be done at home